The North America Male Infertility Market would witness market growth of 6.9% CAGR during the forecast period (2020-2026). There is a gradual rise in the rates of global infertility in both developed and developing countries. Changing habits, delayed pregnancy, and aging are some of the factors behind global cases of infertility. Various techniques like DNA fragmentation, oxidative stress, CASA (computer-assisted semen analysis), sperm penetration assay, sperm agglutination, and microscopic examination are being used to diagnose infertility in males. DNA fragmentation is a new technique that has already gained popularity and is recognized as a standard technique in developing countries. The technique has yet to gain popularity in developing regions and is still to be used as a routine technique due to the cost impediment.
The DNA fragmentation method is predicted to have witnessed a healthy growth in the future due to a high degree of acceptance and the potential of diagnostic procedures to provide a reliable analysis of the integrity of sperm DNA. As DNA aggregation of sperm is one of the key reasons causing male infertility. This method was used for medical purposes in the determination of male infertility.
Continuous R&D efforts are being made to better understand the idiopathic world of infertility. As a result, companies are investing in the development of root cause identification and targeted treatment devices. In addition, the production and commercialization of hormonal therapy are expected to fuel the demand for male infertility during the forecast period. Governments in different countries have taken steps to boost the recovery scenario for infertility-related therapies. In addition, improved safety of patient data due to standardization of legislation is expected to increase consumer demand for infertility treatment.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Male Infertility Market in North America is expected to register a CAGR of 6.9% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the North America Male Infertility Market Analysis
Market Segmentation:
By Treatment
- Assisted Reproductive Technology & Varicocele Surgery
- Medication
By Tests
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Computer Assisted Semen Analysis
- Microscopic Examination
- Sperm Agglutination
- Sperm Penetration Assay
- Other Tests
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Sanofi S.A.
- Bayer AG
- Cadila Healthcare Ltd. (Zydus Cadila)
- Endo International PLC
- Aytu BioScience, Inc.
- Vitrolife AB
- SCSA Diagnostics, Inc.
- Andrology Solutions Limited
- Halotech DNA SL
- Intas Pharmaceutical Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Male Infertility Market, by Treatment
1.4.2 North America Male Infertility Market, by Tests
1.4.3 North America Male Infertility Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Male Infertility Market by Treatment
3.1 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 North America Medication Market by Country
Chapter 4. North America Male Infertility Market by Test
4.1 North America DNA Fragmentation Technique Market by Country
4.2 North America Oxidative Stress Analysis Market by Country
4.3 North America Computer Assisted Semen Analysis Market by Country
4.4 North America Microscopic Examination Market by Country
4.5 North America Sperm Agglutination Market by Country
4.6 North America Sperm Penetration Assay Market by Country
4.7 North America Other Test Market by Country
Chapter 5. North America Male Infertility Market by Country
5.1 US Male Infertility Market
5.1.1 US Male Infertility Market by Treatment
5.1.2 US Male Infertility Market by Test
5.2 Canada Male Infertility Market
5.2.1 Canada Male Infertility Market by Treatment
5.2.2 Canada Male Infertility Market by Test
5.3 Mexico Male Infertility Market
5.3.1 Mexico Male Infertility Market by Treatment
5.3.2 Mexico Male Infertility Market by Test
5.4 Rest of North America Male Infertility Market
5.4.1 Rest of North America Male Infertility Market by Treatment
5.4.2 Rest of North America Male Infertility Market by Test
Chapter 6. Company Profiles
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
TABLE 1 North America Male Infertility Market, 2016 - 2019, USD Million
TABLE 2 North America Male Infertility Market, 2020 - 2026, USD Million
TABLE 3 North America Male Infertility Market by Treatment, 2016 - 2019, USD Million
TABLE 4 North America Male Infertility Market by Treatment, 2020 - 2026, USD Million
TABLE 5 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country, 2016 - 2019, USD Million
TABLE 6 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country, 2020 - 2026, USD Million
TABLE 7 North America Medication Market by Country, 2016 - 2019, USD Million
TABLE 8 North America Medication Market by Country, 2020 - 2026, USD Million
TABLE 9 North America Male Infertility Market by Test, 2016 - 2019, USD Million
TABLE 10 North America Male Infertility Market by Test, 2020 - 2026, USD Million
TABLE 11 North America DNA Fragmentation Technique Market by Country, 2016 - 2019, USD Million
TABLE 12 North America DNA Fragmentation Technique Market by Country, 2020 - 2026, USD Million
TABLE 13 North America Oxidative Stress Analysis Market by Country, 2016 - 2019, USD Million
TABLE 14 North America Oxidative Stress Analysis Market by Country, 2020 - 2026, USD Million
TABLE 15 North America Computer Assisted Semen Analysis Market by Country, 2016 - 2019, USD Million
TABLE 16 North America Computer Assisted Semen Analysis Market by Country, 2020 - 2026, USD Million
TABLE 17 North America Microscopic Examination Market by Country, 2016 - 2019, USD Million
TABLE 18 North America Microscopic Examination Market by Country, 2020 - 2026, USD Million
TABLE 19 North America Sperm Agglutination Market by Country, 2016 - 2019, USD Million
TABLE 20 North America Sperm Agglutination Market by Country, 2020 - 2026, USD Million
TABLE 21 North America Sperm Penetration Assay Market by Country, 2016 - 2019, USD Million
TABLE 22 North America Sperm Penetration Assay Market by Country, 2020 - 2026, USD Million
TABLE 23 North America Other Test Market by Country, 2016 - 2019, USD Million
TABLE 24 North America Other Test Market by Country, 2020 - 2026, USD Million
TABLE 25 North America Male Infertility Market by Country, 2016 - 2019, USD Million
TABLE 26 North America Male Infertility Market by Country, 2020 - 2026, USD Million
TABLE 27 US Male Infertility Market, 2016 - 2019, USD Million
TABLE 28 US Male Infertility Market, 2020 - 2026, USD Million
TABLE 29 US Male Infertility Market by Treatment, 2016 - 2019, USD Million
TABLE 30 US Male Infertility Market by Treatment, 2020 - 2026, USD Million
TABLE 31 US Male Infertility Market by Test, 2016 - 2019, USD Million
TABLE 32 US Male Infertility Market by Test, 2020 - 2026, USD Million
TABLE 33 Canada Male Infertility Market, 2016 - 2019, USD Million
TABLE 34 Canada Male Infertility Market, 2020 - 2026, USD Million
TABLE 35 Canada Male Infertility Market by Treatment, 2016 - 2019, USD Million
TABLE 36 Canada Male Infertility Market by Treatment, 2020 - 2026, USD Million
TABLE 37 Canada Male Infertility Market by Test, 2016 - 2019, USD Million
TABLE 38 Canada Male Infertility Market by Test, 2020 - 2026, USD Million
TABLE 39 Mexico Male Infertility Market, 2016 - 2019, USD Million
TABLE 40 Mexico Male Infertility Market, 2020 - 2026, USD Million
TABLE 41 Mexico Male Infertility Market by Treatment, 2016 - 2019, USD Million
TABLE 42 Mexico Male Infertility Market by Treatment, 2020 - 2026, USD Million
TABLE 43 Mexico Male Infertility Market by Test, 2016 - 2019, USD Million
TABLE 44 Mexico Male Infertility Market by Test, 2020 - 2026, USD Million
TABLE 45 Rest of North America Male Infertility Market, 2016 - 2019, USD Million
TABLE 46 Rest of North America Male Infertility Market, 2020 - 2026, USD Million
TABLE 47 Rest of North America Male Infertility Market by Treatment, 2016 - 2019, USD Million
TABLE 48 Rest of North America Male Infertility Market by Treatment, 2020 - 2026, USD Million
TABLE 49 Rest of North America Male Infertility Market by Test, 2016 - 2019, USD Million
TABLE 50 Rest of North America Male Infertility Market by Test, 2020 - 2026, USD Million
TABLE 51 Key Information – Sanofi S.A.
TABLE 52 Key Information – Bayer AG
TABLE 53 Key Information – Cadila Healthcare Ltd.
TABLE 54 key Information – Endo International PLC
TABLE 55 Key Information – Aytu BioScience, Inc.
TABLE 56 Key Information – Vitrolife AB
TABLE 57 Key Information – SCSA Diagnostics, Inc.
TABLE 58 key Information – Andrology Solutions Limited
TABLE 59 Key information – Halotech DNA SL
TABLE 60 Key Information – Intas Pharmaceutical Ltd.
List of Figures
FIG 1 Methodology for the research